Curis (CRIS)
(Delayed Data from NSDQ)
$16.36 USD
-0.15 (-0.91%)
Updated May 3, 2024 04:00 PM ET
After-Market: $16.67 +0.31 (1.89%) 7:58 PM ET
4-Sell of 5 4
F Value C Growth F Momentum F VGM
Price, Consensus and EPS Surprise
CRIS 16.36 -0.15(-0.91%)
Will CRIS be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for CRIS based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for CRIS
Strength Seen in Curis (CRIS): Can Its 19.5% Jump Turn into More Strength?
2seventy bio, Inc. (TSVT) Expected to Beat Earnings Estimates: Should You Buy?
CRIS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Pharming Group N.V. Sponsored ADR (PHAR) Soars 14.7%: Is Further Upside Left in the Stock?
Curis (CRIS) Reports Q2 Loss, Misses Revenue Estimates
Curis (CRIS) Reports Q1 Loss, Misses Revenue Estimates
Other News for CRIS
Curis to Release First Quarter 2024 Financial Results and Hold Conference Call on May 7, 2024
Top 3 Health Care Stocks That May Collapse In Q2
Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
12 Health Care Stocks Moving In Thursday's Intraday Session
Curis to Present at Upcoming Healthcare Conferences in April